Navigation Links
arGEN-X Presents Significant Progress at BioPharm America 2011
Date:9/7/2011

nsforming the therapeutic antibody space. The speed and productivity of our first three internal programs have enabled us to begin discovery work on two new therapeutic targets. These developments have been instrumental in attracting companies seeking a reliable, robust platform for generation of therapeutic grade antibody candidates. Given this progress, I am excited about arGEN-X' prospects for the coming year."

Note for the editor

About arGEN-X - http://www.arGEN-X.com

arGEN-X is a preclinical stage biopharmaceutical company with a broadly applicable, proprietary SIMPLE Antibody™ platform. The platform allows arGEN-X to create an unparalleled diversity of in vivo generated antibody leads against a broad range of human disease targets. This superior choice of ultra-high affinity and highly potent leads, having best-in-class human homology, allows for more stringent lead selection criteria, thereby increasing the probability of success later in the drug development path. The Company has validated its platform on four human disease targets to date and has broad patent claims in place covering its technology.

arGEN-X' SIMPLE Antibody™ Platform is based on the active immunisation of Camelids with target antigens to deliver antibody variable regions that are perfectly matched to those of human antibodies. The combination of those variable domains with the constant domains of human antibodies, generates full size, human therapeutic antibodies.

The SIMPLE Antibody™ Platform enjoys an independent, unencumbered patent position and is free of target gatekeeping restrictions.

arGEN-X™ and SIMPLE Antibody™ are deposited trademarks of arGEN-X BV.

SIMPLE stands for Superior Immunodiversity with Minimal Protein Lead Engineering.

For further information, please contact:


  
'/>"/>

SOURCE arGEN-X
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology
2. arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform
3. arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development
4. arGEN-X Concludes EUR 12.5 Million Series A Financing Round
5. Elan Pharmaceuticals Presents 7th Annual Danville Concours dElegance Weekend
6. Codexis Presents Carbon Capture Update at DoE/NETL Conference
7. Cardium Presents Second Quarter 2011 Financial Results and Reports on Near-Term Milestones
8. Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimers Disease Research
9. Amerigroup Foundation Presents Grant to Rx Partnership
10. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
11. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Insulet Corporation (NASDAQ: PODD ), the ... ® Insulin Management System, today announced preliminary revenue ... The Company also announced that it will postpone the ... conference call from Thursday, July 30, as originally scheduled. ... , Preliminary second quarter revenue ...
(Date:7/29/2015)... to data released today by the Centers for Medicare ... D premium is expected to remain stable at $32.50, ... Pharmaceutical Care Management Association (PCMA) said. "The ... spot in American health care. By offering an abundance ... edge, cost-saving tools like pharmacy networks and home delivery ...
(Date:7/29/2015)... , July 29, 2015 Unilife Corporation ... developer, manufacturer and supplier of injectable drug delivery ... platform of instant patch pumps for insulin. ... wearable insulin pump that does not require filling ... prefilled and pre-assembled like an insulin pen, only ...
Breaking Medicine Technology:Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5Unilife Introduces World's First Instant Patch Pump for Insulin 2Unilife Introduces World's First Instant Patch Pump for Insulin 3Unilife Introduces World's First Instant Patch Pump for Insulin 4
(Date:7/29/2015)... ... July 30, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, ... posters. The same poster art was used for the Charlotte Coliseum show a month ... and are classic boxing style concert posters. , They measure 22 x 28 ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to data released ... Part D premium is expected to remain stable at $32.50, a figure far lower ... Part D program continues to be a bright spot in American health care. By ...
(Date:7/29/2015)... ... July 29, 2015 , ... Sports fans young and old at ... former players of the Detroit Lions, joined by A Forever Recovery, a holistic treatment ... Wide Receiver Herman Moore, Pro Bowl Offensive Lineman Lomas Brown, and Tight End Rob ...
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, CARE Surrogacy Center ... a treasured member of the CARE extended family. , By shedding light on ... parents across the globe gain a newfound perspective on surrogacy in Mexico. The center ...
(Date:7/29/2015)... FL (PRWEB) , ... July 29, 2015 , ... ... have become increasingly aware of the impact drinking and substance abuse is having ... illness. Financial loss is tagged in the billions per year. [1] Will Wesch, ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Holds Autograph Event with Former Detroit Lions at Cherry Festival 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3
... the prevention of heart disease and is controlled by ... from Leuven, in Belgium, set out to determine whether ... the reduction of blood pressure that accounts for the ... part of a meta-analysis the team compared blood pressure ...
... here is little benefit in replacing older and cheaper ... treating acute, uncomplicated sinusitis, according to US researchers. Researchers ... to determine whether the symptoms could be treated with ... more expensive (second-line) antibiotics. // ,Dr Jay ...
... a way to make wounds heal at least twice ... team at the Australian University of Technology reports they ... number of key hormones involved in the body's own ... ,The researchers believe that although the complex occurs ...
... undergoing high-dose chemotherapy could be eased by electroacupuncture. Nausea ... fight cancer can prove extremely debilitating for patients. ... to lessen the reaction, but in recent years acupuncture ... help. ,Acupuncture involves the insertion of tiny needles at ...
... you ever applied a hot water bottle to an aching ... ache. This treatment delivered with needlepoint accuracy leads to dramatic ... Heat is a long-established method of bringing relief in lower ... the US have developed a high-tech way of using heat.// ...
... first self-contained artificial heart in a 59-year-old man more ... have installed a second such device in a 70-year-old ... recovering in intensive care at Jewish Hospital in Louisville, ... ,The self-contained mechanical heart, made by Abiomed Inc. of ...
Cached Medicine News:
Cleveland Bone Cutter #5, 17cm, 6-3/4"...
To elevate, dissect, scrape and apply traction to bone and soft tissue....
Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps....
The AV Plus DX pacing lead is designed for use with the St. Jude Medical Affinity VDR pulse generator. This single-lead pacing system provides reliable pacing therapy with the added benefits of AV sy...
Medicine Products: